公開報告
公開研究報告
由運營明確公開發布到本站的多智能體研究報告。每份都有分析日期與投資組合經理最終評級。僅供研究參考,不構成投資建議,也不執行交易。
來自投資組合經理的五檔最終評級,不是交易員的中間動作。
- 持有
Meta Platforms Inc Class A
METANASDAQHold META at benchmark weight; do not add aggressively until price and operating evidence confirm that the AI investment cycle is improving returns.
分析日期2026-08-09
分析語言英語
報告數量3 份
閱讀報告 - 減持
Space Exploration Technologies Corp
SPCXNASDAQTrim SPCX to an underweight position: methodically reduce exposure on strength toward $142 with a hard stop at $107.50; preserve a reduced core position for long-term upside catalysts but acknowledge material risks in cash-flow quality, dilution, and revenue sustainability.
分析日期2026-08-08
分析語言英語
報告數量2 份
閱讀報告 - 減持
Hertz Global Holdings Inc
HTZNASDAQReduce HTZ exposure by 40% at $2.12; hold remainder contingent on sustained FCF inflection and technical breakout above $2.50.
分析日期2026-08-07
分析語言英語
報告數量1 份
閱讀報告 - 減持
Zenta Group Company Limited Class A
ZTGNASDAQ閱讀報告
分析日期2026-08-07
分析語言英語
報告數量1 份
閱讀報告 - 賣出
ClearOne, Inc.
CLRONASDAQSell immediately: CLRO is fundamentally insolvent and technically exhausted, with no verified path to profitability or merger completion.
分析日期2026-08-07
分析語言英語
報告數量1 份
閱讀報告 - 減持
TEN Holdings, Inc.
XHLDNASDAQReduce exposure by 50% at $2.81 and hold remainder with a $2.00 stop-loss, awaiting Q2 earnings for evidence of operational inflection.
分析日期2026-08-07
分析語言英語
報告數量1 份
閱讀報告 - 持有
QUALCOMM Incorporated
QCOMNASDAQHold current position in QCOM with disciplined risk controls and clear, observable triggers for future action.
分析日期2026-08-05
分析語言英語
報告數量1 份
閱讀報告 - 持有
Autonomix Medical, Inc.
AMIXNASDAQHold existing position; no new exposure until confirmation of licensing deal or non-dilutive funding.
分析日期2026-08-05
分析語言英語
報告數量1 份
閱讀報告 - 持有
KLA Corporation
KLACNASDAQHold current position; await dual confirmation (technical + behavioral) before increasing exposure.
分析日期2026-08-05
分析語言英語
報告數量1 份
閱讀報告 - 減持
uniQure N.V.
QURENASDAQTrim QURE to a small speculative position and do not rebuild exposure before technical and regulatory confirmation.
分析日期2026-07-30
分析語言英語
報告數量1 份
閱讀報告 - 減持
Verra Mobility Corp. Class A
VRRMNASDAQUnderweight VRRM: trim into the rebound, retain only a small core, and require both cash-flow recovery and a sustained break above $5.43 before rebuilding.
分析日期2026-07-30
分析語言英語
報告數量1 份
閱讀報告 - 減持
SciSparc Ltd.
SPRCNASDAQUnderweight SPRC by selling down to a 0%–0.25% speculative tracking allocation; do not initiate or add after the headline-driven spike.
分析日期2026-07-30
分析語言英語
報告數量1 份
閱讀報告 - 減持
Western Digital Corporation
WDCNASDAQUnderweight WDC by trimming 30%–40% before earnings, retain a reduced core, and rebuild only after fundamental confirmation and sustained technical repair.
分析日期2026-07-30
分析語言英語
報告數量1 份
閱讀報告 - 減持
Prelude Therapeutics, Inc.
PRLDNASDAQTrim PRLD to a tightly capped speculative position before August 19 and do not add without both fundamental and technical confirmation.
分析日期2026-07-30
分析語言英語
報告數量1 份
閱讀報告 - 減持
Nebius Group N.V.
NBISNASDAQReduce NBIS to ~50% of current allocation before tomorrow's Q2 earnings; retain core exposure with a hard stop at $170 while awaiting technical repair and cessation of insider selling.
分析日期2026-07-28
分析語言英語
報告數量1 份
閱讀報告 - 持有
NVIDIA Corporation
NVDANASDAQHold NVDA: maintain core position but do not add — wait for daily technical repair above $205 or post-earnings clarity before increasing exposure.
分析日期2026-07-27
分析語言英語
報告數量4 份
閱讀報告 - 減持
Apple Inc.
AAPLNASDAQ对AAPL执行分阶段减持,保留核心仓位但在财报验证前不新增风险。
分析日期2026-07-27
分析語言中文
報告數量5 份
閱讀報告 - 減持
Netflix, Inc.
NFLXNASDAQReduce NFLX to Underweight — trim 30-40% at market, retain 3-5% core, stop at $65.08, reassess after Q3 earnings.
分析日期2026-07-27
分析語言英語
報告數量1 份
閱讀報告